Conexeu Sciences is trading at $5.01, down -5.47%, after rising 14.72% to $5.30 on September 17.
- No new company-specific announcement explaining the September 18 decline was identified; available coverage lists no current news articles.
- Biotech remains stronger, while major U.S. indexes are only modestly lower, suggesting an isolated pullback or profit-taking.
- Short interest increased 56.4% in August, adding bearish background risk.